Category Archives: Pr Newswire

Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate virtually in a fireside chat at the TD Cowen 4th Annual […]

ADR Ratio Change

September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announces a ratio change on its American Depositary Receipts (“ADR”) from one (1) ADR representing four […]

Global claims guidance leader EvolutionIQ joins as CALI’s inaugural Life Partner

NEW YORK, Sept. 20, 2024 /PRNewswire/ — US-based EvolutionIQ, a global leader in claims guidance technology, has signed on as the Council of Australian Life Insurers (CALI)’s first Life Partner as part of its corporate partner program. The CALI Partner Program is designed to foster collaboration and create a connected ecosystem of industry experts. CALI […]

HWPL Celebrates a Decade of Global Commitment to Peace: Peace Projects in 170 Countries

SEOUL, South Korea, Sept. 20, 2024 /PRNewswire/ — From September 18, 2024, the 10th Anniversary of the HWPL World Peace Summit is being celebrated in South Korea and various locations worldwide reaching 122 countries. Under the theme ‘Creating World Peace Community Through Regional Collaboration’, this event commemorates, global leaders’ and citizens’ commitment to peace that […]

Arcadium Lithium’s 2024 Investor Day Highlights Company’s Strategic Vision and Pathway to Significant Growth

PHILADELPHIA and PERTH, Australia, Sept. 20, 2024 /PRNewswire/ —   Underscores unique position as a vertically integrated, diversified global producer of lithium chemicals with low-cost and high-quality assets Details ongoing expansion programs expected to more than double total sales volumes by 2028 across multiple products and regions Outlines path to Adjusted EBITDA1 of $1.3 billion […]

EQT to acquire Indostar Home Finance, an Indian affordable housing finance company, for INR 17.5 billion (USD 210 million) and invest INR 5 billion to support further growth

STOCKHOLM, Sept. 20, 2024 /PRNewswire/ —  Indostar Home Finance is a fast-growing affordable housing finance company with INR 24 billion (USD 286 million) in assets under management, that has supported over 39,000 low income homeowners and small businesses India’s INR 30 trillion housing finance market presents a multi-decade growth story driven by strong government support, […]

BRESH PARTNERS WITH CARROLL STREET CAPITAL TO LAUNCH BRESH GLOBAL, A GLOBAL BRANDED LIVE EVENTS PLATFORM

NEW YORK and MIAMI and BUENOS AIRES, Argentina, Sept. 20, 2024 /PRNewswire/ — Bresh has partnered with Carroll Street Capital to launch Bresh Global, an international media and branded live events platform. Bresh Global will accelerate Bresh’s growth in the music and entertainment sectors, expanding its presence in key markets worldwide while continuing to deliver […]

Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors

Company actively advancing lead ophthalmology drug candidate to first Investigational New Drug (IND) filing REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Eyconis, Inc., a biopharmaceutical company focused on developing novel, best-in-class therapeutics for eye diseases, today announced that Mark J. Bachleda, Pharm.D., MBA, has been appointed as the Company’s Chief Executive Officer and […]

EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures

                                                 First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of Medicine FDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU ablation for prostate cancer patients EDAP […]

Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors

Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce the appointment of Riccardo Carbucicchio as a […]